Ordered, immediately called back and the same day delivered the order.Very pleased with the work. Thank you for prompt and accurate work https://africarx.co.za/buy-levitra-south-africa.html great prices, delivered on the day of the order. Pleasant managers consult by phone.
NIMH · Science News from 2008 · Maintenance Treatment Crucial for Teens’ Recovery from De. Page 1 of 2
Back to: NIMH Home » Science News » 2008
Maintenance Treatment Crucial for Teens’
NIMH Press Office 301-443-4536 NIMHPress@nih.gov
Long-term maintenance treatment is likely to sustain improvement and prevent recurrence among adolescents with major depression, according to an NIMH-funded study published in the April 2008 issue of the Archives of General Psychiatry.
The study, led by Paul Rohde, Ph.D., of Oregon Research Institute, analyzed data
from the Treatment of Adolescents with Depression Study (TADS), a large, NIMH-
funded trial in which depressed teens were randomized to one of three treatments for 36 weeks—fluoxetine (Prozac), cognitive behavior therapy (CBT) or a combination of
Teens with depression, even if they show a good initial response to treatment, are at high risk for relapse and recurrence. However, guidelines for depression maintenance
treatment are based on adult needs. Rohde and colleagues aimed to identify whether the available guidelines are appropriate for depressed adolescents.
Among the 242 TADS participants analyzed for this study, 61 percent significantly
improved by week 12. The combination group achieved the highest rate of sustained
response (71 percent) compared to the fluoxetine-only group (68 percent) and CBT-only group (42 percent).
The majority (82 percent) of teens who reached a sustained positive response by
week 12 maintained this level of recovery through week 36. Among those in combination treatment, about 89 percent maintained improvement for the full 36
weeks. Among those in the fluoxetine-only group, 74 percent maintained
improvement, but among those in CBT-only treatment, 97 percent maintained their
findings of NIMH-funded investigators, from EurekAlert
The high long-term success rate of CBT suggests that for teens who initially respond to it, CBT may have a preventive effect that helps to sustain positive improvement and potentially avoid relapse or recurrence, even if treatment visits become infrequent, as was the case after the first 12 weeks in the TADS study. Additionally, the relatively lower sustained success rate for fluoxetine suggests that the effectiveness of fluoxetine therapy may plateau at a certain point for some responders, triggering a need for the addition of psychosocial treatment.
“For those teens who respond to fluoxetine only, adding CBT to their treatment regimen early on would likely increase their chances for continued improvement,” suggested Rohde.
The findings help guide clinicians in deciding on the best maintenance course after a teen responds to an initial treatment. They also emphasize the value of ongoing, long-term treatment, even if treatment visits are infrequent, Rohde and colleagues concluded.
http://www.nimh.nih.gov/science-news/2008/maintenance-treatment-crucial-for-teens-recovery-fr.
NIMH · Science News from 2008 · Maintenance Treatment Crucial for Teens’ Recovery from De. Page 2 of 2
Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS. Achievement and maintenance of sustained improvement during TADS continuation and maintenance therapy. Archives of General Psychiatry. 2008 Apr; 65(4): 447-455.
Some NIMH pages link to PDF files. Download Adobe Reader to view and print PDF files.
The National Institute of Mental Health (NIMH) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services.
http://www.nimh.nih.gov/science-news/2008/maintenance-treatment-crucial-for-teens-recovery-fr.
The Effect of Adding Plant Sterols or Stanols to StatinTherapy in Hypercholesterolemic Patients: SystematicReview and Meta-AnalysisJennifer M. Scholle, BS, William L. Baker, PharmD, BCPS, Ripple Talati, PharmD, Craig I. Coleman, PharmDUniversity of Connecticut School of Pharmacy, Storrs (J.M.S., R.T., C.I.C.), Department of Drug Information, Hartford Hospital,Hartford (W.L.B., R.T.), Connecticut
Patients With CKD Should Be Screened Routinely for Depression Laurie Barclay, MD Authors and Disclosures INFORMATION FROM INDUSTRY Assess clinically focused product information on Medscape. Click Here for Product Infosites – Information from Industry. September 11, 2009 — Patients with chronic kidney disease (CKD) have a high prevalence of depression and should be screened routine